These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 99316)

  • 1. Turnover of radiolabelled plasminogen and prothrombin in cirrhosis of the liver.
    Collen D; Rouvier J; Chamone DA; Verstraete M
    Eur J Clin Invest; 1978 Jun; 8(3):185-8. PubMed ID: 99316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    J Clin Invest; 1971 Aug; 50(8):1690-701. PubMed ID: 5163179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunological study of prothrombin in liver cirrhosis.
    Girolami A; Patrassi G; Cappellato G; Quaino V
    Blut; 1980 Jul; 41(1):61-6. PubMed ID: 6996772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
    Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III transfusion in patients with hepatic cirrhosis.
    Schipper HG; ten Cate JW
    Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha 2-Plasmin inhibitor metabolism in patients with liver cirrhosis.
    Knot EA; Drijfhout HR; ten Cate JW; de Jong E; Iburg AH; Kahlé LH; Grijm R
    J Lab Clin Med; 1985 Mar; 105(3):353-8. PubMed ID: 3973471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of prothrombin in liver disease.
    Mannucci PM
    J Clin Pathol; 1970 May; 23(4):291-5. PubMed ID: 5430418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis.
    Leebeek FW; Kluft C; Knot EA; De Maat MP
    J Lab Clin Med; 1989 Apr; 113(4):493-7. PubMed ID: 2703760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects.
    Moja EA; Rocchi E; Benedetti F; Paolillo F; Casalgrandi G; Ponz de Leon M
    Life Sci; 1991; 48(5):409-18. PubMed ID: 1992283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avidin-biotin ELISA for measurement of prothrombin in human plasma.
    Koldas M; Uras F
    Thromb Res; 2001 May; 102(3):221-7. PubMed ID: 11369415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin antigen and coagulant activity in patients with liver disease.
    Corrigan JJ; Jeter M; Earnest DL
    JAMA; 1982 Oct; 248(14):1736-9. PubMed ID: 7120594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of plasma prothrombin levels by a novel Ca2+-dependent prothrombin activator (CA-1) in patients with chronic liver diseases.
    Nomura F; Shimizu S; Ohyama M; Sunaga M; Yokosuka O; Ebara M; Saisho H
    Clin Chim Acta; 2004 Mar; 341(1-2):123-6. PubMed ID: 14967167
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of rabbit plasma-derived factor VII in relation to prothrombin in rabbits.
    Hatton MW; Blajchman MA; Sridhara S; Southward SM; Ross B; Kulzcycky M; Clarke BJ
    Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E507-15. PubMed ID: 11500306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Description of a new method of plasminogen determination. Its application to the study of liver cirrhosis].
    Dray L
    Hemostase; 1966; 6(2):105-27. PubMed ID: 5954763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.